What's sending this ASX 300 share 10% higher today?

Shareholders of this company will be smiling on Friday.

| More on:
A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The APM Human Services International Ltd (ASX: APM) share price is ending the week in style.

In morning trade, the ASX 300 share is up almost 11% to $2.06.

Why is this ASX 300 share rocketing higher?

Investors have been scrambling to buy this human services provider's shares today after it announced a major contract win in the UK.

According to the release, APM has been confirmed as the successful bidder to deliver Functional Assessment Services (FAS) on behalf of the Department for Work and Pensions (DWP) in the London, South-East, and East Anglia region.

The release notes that these services provide an assessment of the functional impact of disability and illness on an individual's daily life and their needs as a result of their health conditions.

The contract is for an initial five-year period and has a total value of $720 million or 384 million pounds. It is expected to commence in 2024 and includes an option for a two-year extension.

It is worth noting that this revenue won't all flow through to the bottom line, though. The company will require an investment in capital expenditure and working capital in FY 2023 and FY 2024 before the contract commences.

Speaking of profits, the ASX 300 share has also provided the market with an update on its performance and guidance for FY 2023.

Trading update

Pleasingly, APM continues to make positive progress in executing its strategy. It also continues to increase its average tenure across key programs through new contract awards, retenders, and extensions. This has seen the base tenure (excluding future options) being more than 3 years across its largest contracts.

As for its guidance, the company is expecting its FY 2023 underlying net profit after tax and before amortisation (NPATA) to be in the range of $175 million and $180 million.

This will be up from $166.3 million despite the impacts of lower client flow into Employment Services Programs, a shortage of qualified allied health professionals, and higher interest costs.

Commenting on the contract award, APM Group's CEO, Michael Anghie, said:

We look forward to partnering with the Department of Work and Pensions to deliver these important Functional Assessment Services. APM is one of the leading health service providers in Australia delivering Assessment Services across a wide range of sectors including Health, Disability and Aged Care.

The opportunity to deliver Functional Assessment Services demonstrates the strength of our local service delivery team, our reputation for service excellence, and our ability to leverage APM's expertise across regions and markets. The contract win continues the trend of APM executing its strategy and diversifying its business globally both geographically and in terms of service and revenue models.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended APM Human Services International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »

research with microscope
Healthcare Shares

This ASX healthcare stock just changed its debt. Here's why it matters

Shares in Mesoblast edge higher after the company announces a major change to its debt and funding structure.

Read more »

stock growth chart
Healthcare Shares

Will CSL shares crash again in 2026?

CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Here's the dividend forecast out to 2030 for Sigma shares

This business could pay healthy dividends in the coming years…

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Mayne Pharma signals short-term pain as it resets for growth

It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals.

Read more »

A man packs up a box of belongings at his desk as he prepares to leave the office.
Healthcare Shares

Regis Healthcare shares down 2% as CEO resigns

Dr Mellors will step down as CEO after more than six years in the role.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Telix shares storm higher on big US and China news

Let's see why this biotech is getting attention on Monday.

Read more »